Found 12 matching trials
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis PHASE3 The RAISE-XT study is an open-label extension study to evaluate the long-te...
Show More Learn More & Join Trial
Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients PHASE2 The purpose of the study is to evaluate the safety and efficacy of zilucopl...
Show More Location
Investigative Site
Learn More & Join Trial
A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women PHASE1 The purpose of this study is to assess the steady state (SS) concentrations...
Show More Learn More & Join Trial
A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis PHASE3 The purpose of this study is to evaluate the effectiveness, safety and tole...
Show More Learn More & Join Trial
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis PHASE2 The purpose of this study is to assess the pharmacokinetics, pharmacodynami...
Show More Learn More & Join Trial
Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis PHASE3 The RAISE study is a multicenter, randomized, double-blind, placebo control...
Show More Location
Site 41: Diagnostic and Medical Clinic
Learn More & Join Trial
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors PHASE3 The purpose of the study is to evaluate the safety and tolerability of swit...
Show More Learn More & Join Trial
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis PHASE2 The purpose of the study is to evaluate the safety and efficacy of RA101495...
Show More Location
Diagnostic and Medical Clinic - Mobile
Learn More & Join Trial
Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab PHASE2 The purpose of the study is to evaluate the safety and efficacy of RA101495...
Show More Location
Investigative Site
Learn More & Join Trial
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis PHASE3 The purpose of this study is to assess the long-term safety and tolerabilit...
Show More Status
Enrolling By Invitation
Learn More & Join Trial